‘Super’ Germs Developing Faster Than Drugs Needed to Treat Them

In March, Tom Frieden, M.D., M.P.H. , director of the U.S. Centers for Disease Control and Prevention alerted the public to a family of 70 bacteria that have the propensity and ability to develop into “nightmare bacteria .” On Wednesday, the Infectious Diseases Society of America shared the results of research into the development of new antibiotics, drugs that will be needed to successfully treat the “nightmare bacteria” and other organisms that continue to develop resistance to available antibiotics.